Exact Mass: 430.3016
Exact Mass Matches: 430.3016
Found 333 metabolites which its exact mass value is equals to given mass value 430.3016,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ruscogenin
Ruscogenin is a triterpenoid. Ruscogenin is a natural product found in Cordyline rubra, Cordyline banksii, and other organisms with data available. Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Ruscogenin exerts significant anti-inflammatory and anti-thrombotic activities. Ruscogenin has orally bioactivity[1][2]. Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Ruscogenin exerts significant anti-inflammatory and anti-thrombotic activities. Ruscogenin has orally bioactivity[1][2].
Hocogenin
Hecogenin is a triterpenoid. Hecogenin is a natural product found in Yucca gloriosa, Allium rotundum, and other organisms with data available.
Australigenin
Sapogenin from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-HOCA)
7alpha-Hydroxy-3-oxo-4-cholestenoate, also known as 7-Hoca, is a member of the class of compounds known as monohydroxy bile acids, alcohols, and derivatives. Thes compounds are bile acids, alcohols, or any of their derivatives bearing a hydroxyl group. 7alpha-Hydroxy-3-oxo-4-cholestenoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in metabolic disorders such as 27-hydroxylase deficiency, familial hypercholanemia (FHCA), and Zellweger syndrome. 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in the primary bile acid biosynthesis pathway. 7alpha-Hydroxy-3-oxo-4-cholestenoate is created from either 3beta,7alpha-dihydroxy-5-cholestenoate or 7alpha,26-dihydroxy-4-cholesten-3-one through the actions of HSD3B7 (EC 1.1.1.181) or CYP27A (EC 1.14.13.15), respectively.
Barogenin
Cryptogenin is a constituent of Balanites aegyptiaca (soapberry tree fruits) Constituent of Balanites aegyptiaca (soapberry tree fruits).
24-Oxo-1alpha,25-dihydroxyvitamin D3
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
Schidigeragenin C
Genin from Yucca schidigera (Mojave yucca). Schidigeragenin C is found in fruits. Schidigeragenin C is found in fruits. Genin from Yucca schidigera (Mojave yucca
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0)
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. [HMDB] MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
25-Hydroxyvitamin D3-26,23-lactol
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
(25R)-3beta-hydroxycholest-5-en-7-one-26-oate
(25R)-3beta-hydroxycholest-5-en-7-one-26-oate is also known as (3beta,25R)-3-Hydroxy-7-oxocholest-5-en-26-Oate. (25R)-3beta-hydroxycholest-5-en-7-one-26-oate is considered to be practically insoluble (in water) and acidic
Ruscogenin
MG(PGF1alpha/0:0/0:0)
MG(PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/PGF1alpha/0:0)
MG(0:0/PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
DG(2:0/18:1(12Z)-2OH(9,10)/0:0)
DG(2:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:1(12Z)-2OH(9,10)/2:0/0:0)
DG(18:1(12Z)-2OH(9,10)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/18:1(12Z)-2OH(9,10))
DG(2:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:1(12Z)-2OH(9,10)/0:0/2:0)
DG(18:1(12Z)-2OH(9,10)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Nuatigenin
Nuatigenin belongs to furospirostanes and derivatives class of compounds. Those are heterocyclic steroids containing a furospirostane moiety, which a skeleton characterized by the presence of a 1,6-dioxaspiro[4.4]nonane ring system and an androstane moiety. Nuatigenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Nuatigenin can be found in oat, which makes nuatigenin a potential biomarker for the consumption of this food product.
Kuguacin E
Kuguacin e is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Kuguacin e can be found in bitter gourd, which makes kuguacin e a potential biomarker for the consumption of this food product.
Yuccagenin
Yuccagenin is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Yuccagenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Yuccagenin can be found in fenugreek, which makes yuccagenin a potential biomarker for the consumption of this food product.
Cryptogenin
4-(3-ACO-10,13-DI-ME-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)-PENTANOIC ACID ME ESTER
3beta,6alpha,20xi-Trihydroxy-5alpha-cholesta-9(11),24-dien-23-on|3beta,6alpha,20xi-trihydroxy-5alpha-cholesta-9(11),24-dien-23-one
(5alpha,12beta,25R)-12-Hydroxyspirostan-3-one|Hispidogenin
(20S,22E)-cholesta-1,22-diene-16beta,18,20-triol-3-one
(5alpha,12alpha,25S)-12-Hydroxyspirostan-3-one|Torvogenin
24xi-hydroperoxy-6beta-hydroxycholesta-4,25-dien-3-one
12alpha,24alpha-dihydroxy-20,24-dimethyl-25-norscalar-17-ene-18,24-carbolactone|phyllolactone E
(7R*,8R*)-6-hydroxy-2,8-dimethyl-2-((3E)-4,8,12-trimethyl-7,8-dihydroxytrideca-3,11-dien-1-yl)chroman|(7R*,8R*)-6-hydroxy-2,8-dimethyl-2-<(3E)-4,8,12-trimethyl-7,8-dihydroxytrideca-3,11-dien-1-yl>chroman
3alpha-hydroxy-21alpha-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
3beta,9alpha-dihydroxycholest-7-en-6,23-dione|grandol D
16,22-epoxy-20beta,23S-dihydroxycholest-1-ene-3-one
23alpha-hydroxy-3-oxo-25,26,27-trinordammar-24,20alpha-olide
(25R)-Spirost-4-en-2alpha,3beta-diol|(25R)-spirost-4-ene-2alpha,3beta-diol|yuccagenin
(3S,5Z,7E)-3,23,25-Trihydroxy-9,10-secocholesta-5,7,10(19)-trien-24-one
25-hydroperoxy-6beta-hydroxycholesta-4,23-dien-3-one
cholesta-1,4-dien-12beta,16beta,20alpha-triol-3-one
(3beta)-25,26,27-trinorcucurbita-5,24-diene-7,23-dione-3,29-diol|balsaminol D
gammar-Lactone-(3S,5E,7E,10S)-3,23,25-Trihydroxy-9,10-secocholesta-5,7-dien-26-oic acid
1,2-Dihydro-(16beta,22E)-16,18,20-Trihydroxycholesta-1,4,22-trien-3-one
3beta-hydroxy-5alpha,6alpha-epoxy-9-oxo-9,11-seco-5alpha-cholest-7-en-11-al
(2E,6E)-2-(10(S),11(S)-dihydroxygeranylgeranyl)-6-methylquinol|2-(10,11-Dihydroxygeranylgeranyl)-6-methyl-1,4-benzenediol
2alpha,11-dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione
(1S,23R,5Z,7E)-1,3,25-Trihydroxy-9,10-secocholesta-5,7,10(19)-trien-23-one
1,2-Dihydro,27-nor-(16beta,22E)-16,18,20-Trihydroxy-24-methylcholesta-1,4,22-trien-3-one
(25RS)-Ruscogenin
Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su
Pennogenin
Pennogenin is an oxaspiro compound that is spirost-5-en substituted by hydroxy groups at positions 3 and 17 (3beta,25R stereoisomer). It has a role as a metabolite. It is a 17alpha-hydroxy steroid, an oxaspiro compound, an organic heterohexacyclic compound, a sapogenin and a 3beta-hydroxy-Delta(5)-steroid. It derives from a hydride of a spirostan. Pennogenin is a natural product found in Paris polyphylla var. chinensis, Polygonatum stenophyllum, and other organisms with data available. An oxaspiro compound that is spirost-5-en substituted by hydroxy groups at positions 3 and 17 (3beta,25R stereoisomer).
C27H42O4_(3beta,5alpha,8xi,9xi,14xi,25S)-3-Hydroxyspirostan-12-one
3beta-Hydroxy-5alpha,6alpha-epoxy-9-oxo-9,10-seco-5-cholest-7-en-11-al
(5Z,7E)-(1S,3R,24R,25R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24R,25S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24S,25R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24S,25S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
1α,25-dihydroxy-24-oxovitamin D3 / 1α,25-dihydroxy-24-oxocholecalciferol
(23S)-23,25-dihydroxy-24-oxovitamin D3 / (23S)-23,25-dihydroxy-24-oxocholecalciferol
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol / (23S,25R)-25-hydroxycholecalciferol 26,23-lactol
(5Z,7E,22E)-(1S,3R,24R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24,25-tetrol
(5Z,7E,22E)-(1S,3R,24S)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24,25-tetrol
(5Z,7E,22E)-(1S,3R,25R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25,26-tetrol
(5Z,7E,22E)-(1S,3R,25S)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25,26-tetrol
1,25-Dihydroxy-23-oxo-vitamin D3
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
Australigenin
Schidigeragenin C
(24R,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24R,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24S,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24S,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
1alpha,25-dihydroxy-18-oxovitamin D3 / 1alpha,25-dihydroxy-18-oxocholecalciferol
1alpha,25-dihydroxy-24-oxovitamin D3
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
[1R-(1a,2b,3a,5a)]-5-Hydroxy-2-[(1-methoxy-1-methylethoxy)methyl]-3-[(tetrahydro-2H-pyran-2-yl)oxy]cyclopentaneheptanoic acidmethylester
Calcipotriene hydrate
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D003879 - Dermatologic Agents
2-ethylhexyl prop-2-enoate,2-methylpropyl 2-methylprop-2-enoate,styrene
(EZ)-3-hydroxy-6-ethylidene-7-keto-5-cholan-24-oic acid methyl ester
12-Epi-Deoxoscalarin
A scalarane sesterterpenoid that is the deoxo derivative of 12-epi-scalarin. It has been isolated from the sponge,Hyattella species.
(1S)-1,25-dihydroxy-24-oxocalciol
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
(25R)-3beta-Hydroxycholest-5-en-7-one-26-Oic acid
A cholestanoid resulting from the oxidation of (25R)-3beta,26-dihydroxycholest-5-en-7-one to the corresponding carboxylic acid.
(24R,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24R,25R)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24R,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24R,25S)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24S,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24S,25R)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24S,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24S,25S)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
1alpha,25-dihydroxy-18-oxovitamin D3/1alpha,25-dihydroxy-18-oxocholecalciferol
23(S),25-dihydroxy-24-oxovitamin D3
A hydroxycalciol that is 25-hydroxyvitamin D3 carrying an additional hydroxy group at position 23 (with 23S-configuration) and an oxo group at position 24. An intermediate in the degradation pathway of 25-OH-vitamin D3.
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol/(23S,25R)-25-hydroxycholecalciferol 26,23-lactol
(22E)-(24R)-1alpha,24,25-trihydroxy-22,23-didehydrovitamin D3/(22E)-(24R)-1alpha,24,25-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(24S)-1alpha,24,25-trihydroxy-22,23-didehydrovitamin D3/(22E)-(24S)-1alpha,24,25-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(25R)-1alpha,25,26-trihydroxy-22,23-didehydrovitamin D3/(22E)-(25R)-1alpha,25,26-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(25S)-1alpha,25,26-trihydroxy-22,23-didehydrovitamin D3/(22E)-(25S)-1alpha,25,26-trihydroxy-22,23-didehydrocholecalciferol
(1R,4S,5S,8R,9R,12R,13S,16S)-16-hydroxy-5,9,17,17-tetramethyl-8-(4-oxopentan-2-yl)-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadecan-3-one
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoic acid
(1R,2S,4S,7S,8R,9S,12S,13S,16S,18S)-16-Hydroxy-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-10-one
17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid
(16R)-16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid
(6R)-6-[(7R,10R,13R,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] acetate
(2alpha,8xi,9xi,14xi,16xi,17xi)-Spirost-5-en-2,3-diol
7alpha-hydroxy-3-oxo-4-cholestenoic acid
A cholestanoid that is cholest-4-en-26-oic acid substituted by an alpha-hydroxy group at position 7 and an oxo group at position 3. It is an intermediate metabolite in the bile acid synthesis.
